Stock Watch: The Pandemic Cannot Mask Roche’s Weaknesses
Declining COVID-19 Sales, Biosimilar Exposure And Pipeline Failures Bite
Executive Summary
Declining COVID-19-related diagnostic and therapeutic sales are likely to expose long-standing weaknesses and amplify the effects of new pressures that were masked during the pandemic.